000 01208 a2200289 4500
005 20250514162236.0
264 0 _c20040805
008 200408s 0 0 eng d
022 _a0929-5305
024 7 _a10.1023/b:thro.0000003309.34726.b4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerheugt, Freek W A
245 0 0 _aGlycoprotein IIb/IIIa blockers in non-ST elevation acute coronary syndromes: only for well defined subgroups or a therapeutic option for all patients?
_h[electronic resource]
260 _bJournal of thrombosis and thrombolysis
_cApr 2003
300 _a81-4 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcute Disease
650 0 4 _aContraindications
650 0 4 _aCoronary Disease
_xdrug therapy
650 0 4 _aElectrocardiography
650 0 4 _aHumans
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aPlatelet Glycoprotein GPIIb-IIIa Complex
_xantagonists & inhibitors
650 0 4 _aPractice Guidelines as Topic
773 0 _tJournal of thrombosis and thrombolysis
_gvol. 15
_gno. 2
_gp. 81-4
856 4 0 _uhttps://doi.org/10.1023/b:thro.0000003309.34726.b4
_zAvailable from publisher's website
999 _c14354985
_d14354985